Yearly Archives: 2023

/2023

Data Security and Protection Toolkit Workshop now on-demand

Community pharmacy contractors can now access a recording of PSNC’s recent online workshop to help with completion of the Data Security and Protection Toolkit for 2022/2023. Feedback on the webinar “Very worthwhile watching.” “Perfect. To the point, no wasted time. Answer the questions clearly and concisely.” “I think it was long enough, slides were clear [...]

The post Data Security and Protection Toolkit Workshop now on-demand appeared first on PSNC Website.

By |February 27th, 2023|Lexpos News|Comments Off on Data Security and Protection Toolkit Workshop now on-demand

Service case study: Liverpool Community Pharmacy Sexual Health Service

The Liverpool Community Pharmacy Sexual Health Service is commissioned by Liverpool University Hospitals NHS Foundation Trust, on behalf of Liverpool City Council, to provide sexual health services to the residents of Liverpool. The pharmacy service forms part of an integrated sexual health service offer, that incorporates community contraception services, genito-urinary medicine, and sexual health promotion. [...]

The post Service case study: Liverpool Community Pharmacy Sexual Health Service appeared first on PSNC Website.

By |February 27th, 2023|Lexpos News|Comments Off on Service case study: Liverpool Community Pharmacy Sexual Health Service

Contractor Notice: 11 SSPs for Pen V and Sandrena further extended

Update 27/4/2023 – The Department of Health and Social Care (DHSC) has provided an update on 11 Serious Shortage Protocols (SSPs) that were due to expire 28 April 2023. The following SSPs have been further extended to 12 May 2023. Please note that unless there are unexpected changes to the supply situation this will be [...]

The post Contractor Notice: 11 SSPs for Pen V and Sandrena further extended appeared first on PSNC Website.

By |February 27th, 2023|Lexpos News|Comments Off on Contractor Notice: 11 SSPs for Pen V and Sandrena further extended

MHRA Drug Safety Update February 2023

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 16 Issue 7 February 2023) has been published and includes articles on: COVID-19 vaccines and medicines: updates for February 2023 Letters and medicine recalls sent to healthcare professionals in January 2023 To see the latest MHRA Drug Safety Updates in full, visit [...]

The post MHRA Drug Safety Update February 2023 appeared first on PSNC Website.

By |February 27th, 2023|Lexpos News|Comments Off on MHRA Drug Safety Update February 2023

Medicine Supply Notification: Latanoprost (Monopost®) 50 microgram/ml eye drops 0.2 ml unit dose (preservative free)

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Latanoprost (Monopost®) 50 microgram/ml eye drops 0.2 ml unit dose (preservative free). MSN/2023/023 Tier 3 – high impact Date of issue 27th February 2023 Latanoprost (Monopost®) 50microgram/ml eye drops 0.2ml unit dose (preservative free) is out of stock until 17th March [...]

The post Medicine Supply Notification: Latanoprost (Monopost®) 50 microgram/ml eye drops 0.2 ml unit dose (preservative free) appeared first on PSNC Website.

By |February 27th, 2023|Lexpos News|Comments Off on Medicine Supply Notification: Latanoprost (Monopost®) 50 microgram/ml eye drops 0.2 ml unit dose (preservative free)